177 related articles for article (PubMed ID: 36502409)
21. Surveillance for variants of SARS-CoV-2 to inform risk assessments.
Attar Cohen H; Mesfin S; Ikejezie J; Kassamali Z; Campbell F; Adele S; Guinko N; Idoko F; Mirembe BB; Mitri ME; Nezu I; Shimizu K; Ngongheh AB; Sklenovska N; Gumede N; Mosha FS; Mohamed B; Corpuz A; Pebody R; Marklewitz M; Gresh L; Mendez Rico JA; Hundal K; Kato M; Babu A; Archer BN; le Polain de Waroux O; Van Kerkhove MD; Mahamud A; Subissi L; Pavlin BI
Bull World Health Organ; 2023 Nov; 101(11):707-716. PubMed ID: 37961054
[TBL] [Abstract][Full Text] [Related]
22. Tracking the molecular evolution and transmission patterns of SARS-CoV-2 lineage B.1.466.2 in Indonesia based on genomic surveillance data.
Zhu M; Zeng Q; Saputro BIL; Chew SP; Chew I; Frendy H; Tan JW; Li L
Virol J; 2022 Jun; 19(1):103. PubMed ID: 35710544
[TBL] [Abstract][Full Text] [Related]
23. Role of genomics in combating COVID-19 pandemic.
Saravanan KA; Panigrahi M; Kumar H; Rajawat D; Nayak SS; Bhushan B; Dutt T
Gene; 2022 May; 823():146387. PubMed ID: 35248659
[TBL] [Abstract][Full Text] [Related]
24. Genomic surveillance of the Lambda SARS-CoV-2 variant in a global phylogenetic context.
Mestanza O; Lizarraga W; Padilla-Rojas C; Jimenez-Vasquez V; Hurtado V; Molina IS; Barcena L; Acedo S; Nuñez A; Gordillo S; Sevilla N; Medrano P; Bailon H; Cáceres O; Galarza M; Rojas-Serrano N; Vargas-Herrera N; Lope-Pari P; Huayra J; Araujo-Castillo RV; Solari L
J Med Virol; 2022 Oct; 94(10):4689-4695. PubMed ID: 35644902
[TBL] [Abstract][Full Text] [Related]
25. Impact of lockdown on Covid-19 case fatality rate and viral mutations spread in 7 countries in Europe and North America.
Pachetti M; Marini B; Giudici F; Benedetti F; Angeletti S; Ciccozzi M; Masciovecchio C; Ippodrino R; Zella D
J Transl Med; 2020 Sep; 18(1):338. PubMed ID: 32878627
[TBL] [Abstract][Full Text] [Related]
26. Challenges and Opportunities for Global Genomic Surveillance Strategies in the COVID-19 Era.
Ling-Hu T; Rios-Guzman E; Lorenzo-Redondo R; Ozer EA; Hultquist JF
Viruses; 2022 Nov; 14(11):. PubMed ID: 36423141
[TBL] [Abstract][Full Text] [Related]
27. SARS-CoV-2 genomic epidemiology: data and sequencing infrastructure.
Merhi G; Koweyes J; Salloum T; Khoury CA; Haidar S; Tokajian S
Future Microbiol; 2022 Sep; 17():1001-1007. PubMed ID: 35899481
[TBL] [Abstract][Full Text] [Related]
28. SARS-CoV-2 Wave Two Surveillance in East Asia and the Pacific: Longitudinal Trend Analysis.
Post LA; Lin JS; Moss CB; Murphy RL; Ison MG; Achenbach CJ; Resnick D; Singh LN; White J; Boctor MJ; Welch SB; Oehmke JF
J Med Internet Res; 2021 Feb; 23(2):e25454. PubMed ID: 33464207
[TBL] [Abstract][Full Text] [Related]
29. EDGE COVID-19: a web platform to generate submission-ready genomes from SARS-CoV-2 sequencing efforts.
Lo CC; Shakya M; Connor R; Davenport K; Flynn M; Gutiérrez AMY; Hu B; Li PE; Jackson EP; Xu Y; Chain PSG
Bioinformatics; 2022 May; 38(10):2700-2704. PubMed ID: 35561186
[TBL] [Abstract][Full Text] [Related]
30. SARS-CoV-2 Whole Genome Amplification and Sequencing for Effective Population-Based Surveillance and Control of Viral Transmission.
Harilal D; Ramaswamy S; Loney T; Suwaidi HA; Khansaheb H; Alkhaja A; Varghese R; Deesi Z; Nowotny N; Alsheikh-Ali A; Abou Tayoun A
Clin Chem; 2020 Nov; 66(11):1450-1458. PubMed ID: 32715310
[TBL] [Abstract][Full Text] [Related]
31. Improved SARS-CoV-2 sequencing surveillance allows the identification of new variants and signatures in infected patients.
Grimaldi A; Panariello F; Annunziata P; Giuliano T; Daniele M; Pierri B; Colantuono C; Salvi M; Bouché V; Manfredi A; Cuomo MC; Di Concilio D; Tiberio C; Fiorenza M; Portella G; Cimmino I; Sorrentino A; Fusco G; Granata MR; Cerino P; Limone A; Atripaldi L; Ballabio A; Cacchiarelli D
Genome Med; 2022 Aug; 14(1):90. PubMed ID: 35962405
[TBL] [Abstract][Full Text] [Related]
32. SARS-CoV-2 genomics and impact on clinical care for COVID-19.
Lorenzo-Redondo R; de Sant'Anna Carvalho AM; Hultquist JF; Ozer EA
J Antimicrob Chemother; 2023 Nov; 78(Suppl 2):ii25-ii36. PubMed ID: 37995357
[TBL] [Abstract][Full Text] [Related]
33. Building up a genomic surveillance platform for SARS-CoV-2 in the middle of a pandemic: a true North-South collaboration.
Khan W; Kabir F; Kanwar S; Aziz F; Muneer S; Kalam A; Rajab Ali MN; Ansari N; Vanaerschot M; Ahyong V; Fahsbender L; Kalantar K; Black A; Glascock A; Gil J; Ayscue P; Tato C; Jehan F; Nisar I
BMJ Glob Health; 2023 Nov; 8(11):. PubMed ID: 37984892
[TBL] [Abstract][Full Text] [Related]
34. Mobilisation and analyses of publicly available SARS-CoV-2 data for pandemic responses.
Rahman N; O'Cathail C; Zyoud A; Sokolov A; Oude Munnink B; Grüning B; Cummins C; Amid C; Nieuwenhuijse DF; Visontai D; Yuan DY; Gupta D; Prasad DK; Gulyás GM; Rinck G; McKinnon J; Rajan J; Knaggs J; Skiby JE; Stéger J; Szarvas J; Gueye K; Papp K; Hoek M; Kumar M; Ventouratou MA; Bouquieaux MC; Koliba M; Mansurova M; Haseeb M; Worp N; Harrison PW; Leinonen R; Thorne R; Selvakumar S; Hunt S; Venkataraman S; Jayathilaka S; Cezard T; Maier W; Waheed Z; Iqbal Z; Aarestrup FM; Csabai I; Koopmans M; Burdett T; Cochrane G
Microb Genom; 2024 Feb; 10(2):. PubMed ID: 38358325
[TBL] [Abstract][Full Text] [Related]
35. SARS-CoV-2 Infections in Vaccinated and Unvaccinated Populations in Camp Lemonnier, Djibouti, from April 2020 to January 2022.
Arnold CE; Voegtly LJ; Stefanov EK; Lueder MR; Luquette AE; Miller RH; Miner HL; Bennett AJ; Glang L; McGinnis TN; Reisinger KE; Dugan JW; Mangat MA; Silberger DJ; Pavlicek RL; Watters CM; Rice GK; Malagon F; Cer RZ; Eggan SM; Bishop-Lilly KA
Viruses; 2022 Aug; 14(9):. PubMed ID: 36146724
[TBL] [Abstract][Full Text] [Related]
36. Benchmarking and Assessment of Eight
Gupta AK; Kumar M
OMICS; 2022 Jul; 26(7):372-381. PubMed ID: 35759429
[TBL] [Abstract][Full Text] [Related]
37. Identification of SARS-CoV-2 variants using viral sequencing for the Centers for Disease Control and Prevention genomic surveillance program.
Goswami C; Sheldon M; Bixby C; Keddache M; Bogdanowicz A; Wang Y; Schultz J; McDevitt J; LaPorta J; Kwon E; Buyske S; Garbolino D; Biloholowski G; Pastuszak A; Storella M; Bhalla A; Charlier-Rodriguez F; Hager R; Grimwood R; Nahas SA
BMC Infect Dis; 2022 Apr; 22(1):404. PubMed ID: 35468749
[TBL] [Abstract][Full Text] [Related]
38. Rapid automated validation, annotation and publication of SARS-CoV-2 sequences to GenBank.
Underwood BA; Yankie L; Nawrocki EP; Palanigobu V; Gotvyanskyy S; Calhoun VC; Kornbluh M; Smith TG; Fleischmann L; Sinyakov D; Bollin CJ; Karsch-Mizrachi I
Database (Oxford); 2022 Mar; 2022():. PubMed ID: 35230423
[TBL] [Abstract][Full Text] [Related]
39. Comparative Analysis of Library Preparation Approaches for SARS-CoV-2 Genome Sequencing on the Illumina MiSeq Platform.
Gladkikh A; Klyuchnikova E; Pavlova P; Sbarzaglia V; Tsyganova N; Popova M; Arbuzova T; Sharova A; Ramsay E; Samoilov A; Dedkov V; Totolian A
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768696
[TBL] [Abstract][Full Text] [Related]
40. The lag in SARS-CoV-2 genome submissions to GISAID.
Kalia K; Saberwal G; Sharma G
Nat Biotechnol; 2021 Sep; 39(9):1058-1060. PubMed ID: 34376850
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
